MAR-FARMA

SPM-OK 21 + 1 SWALLOWABLE TABLETS

SPM-OK 21 + 1 SWALLOWABLE TABLETS

Skip to product information
1 of 1
  • Secure payment
  • Discreet and sanitized package
  • Fast and safe shipping

Description

Descriptive sheet

SPM-OK

Tablets to combat the symptoms of premenstrual syndrome:
- Mastodynia
- Heachache
- Mood swings
- Anxiety
- Irritability
- Craving for sweets
- Pain
- Insomnia
- Depression

Ingredients
Magnesium, zinc, vitamin E, vitamin B6, vitamin B2, vitamin B1, vitamin D, griffonia simplicifolia, chasteberry, borage oil.

How to use
1 tablet per day, away from your main meal. Start taking the tablets from the last day of your menstrual cycle until the first day of your next cycle (days 21-22).

Format
1 blister pack of 22 tablets inserted in a box with information leaflet.

Cod. 9421

MAR-FARMA

SPM-OK 21 + 1 SWALLOWABLE TABLETS

SPM-OK 21 + 1 SWALLOWABLE TABLETS

MINSAN code: 907055899
Previous price: €22,72
Regular price €22,72
Regular price €23,00 Sale price €22,72
-1% Sold out
Tax included. Shipping calculated at checkout.
View full details

Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.